Found: 123
Select item for more details and to access through your institution.
Validation of a Dyspnea Visual Analog Scale in Fibrotic Interstitial Lung Disease.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 7, p. 1007, doi. 10.1513/AnnalsATS.202307-658OC
- By:
- Publication type:
- Article
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort.
- Published in:
- Respirology, 2024, v. 29, n. 7, p. 596, doi. 10.1111/resp.14695
- By:
- Publication type:
- Article
Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in mice.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64548-w
- By:
- Publication type:
- Article
Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.91876
- By:
- Publication type:
- Article
Exploring alveolar recruitability using positive end-expiratory pressure in mice overexpressing TGF-β1: a structure–function analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58213-5
- By:
- Publication type:
- Article
Sex and Racial Differences in Lung Biopsies for Interstitial Lung Diseases in Canada.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 3, p. 516, doi. 10.1513/AnnalsATS.202308-703RL
- By:
- Publication type:
- Article
An elementary approach to the inverse first-passage-time problem for soft-killed Brownian motion.
- Published in:
- Journal of Applied Probability, 2024, v. 61, n. 1, p. 279, doi. 10.1017/jpr.2023.39
- By:
- Publication type:
- Article
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 4, p. 362, doi. 10.1164/rccm.202307-1154WS
- By:
- Publication type:
- Article
Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations: An Official American Thoracic Society Clinical Practice Guideline.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 2, p. 137, doi. 10.1164/rccm.202306-1113ST
- By:
- Publication type:
- Article
Examining the incidence of interstitial lung disease subtypes in South America.
- Published in:
- Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia, 2024, v. 50, n. 1, p. 1, doi. 10.36416/1806-3756/e20240028
- By:
- Publication type:
- Article
Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 12, p. 5536, doi. 10.1007/s12325-023-02668-x
- By:
- Publication type:
- Article
Reply to: Huang et al.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 11, p. 1242, doi. 10.1164/rccm.202309-1562LE
- By:
- Publication type:
- Article
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2311, doi. 10.1007/s10067-023-06623-7
- By:
- Publication type:
- Article
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial.
- Published in:
- Respirology, 2023, v. 28, n. 5, p. 465, doi. 10.1111/resp.14452
- By:
- Publication type:
- Article
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0283110
- By:
- Publication type:
- Article
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.
- Published in:
- European Respiratory Review, 2023, v. 32, n. 167, p. 1, doi. 10.1183/16000617.0206-2022
- By:
- Publication type:
- Article
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 1, p. 102, doi. 10.1164/rccm.202205-0910LE
- By:
- Publication type:
- Article
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse.
- Published in:
- 2022
- By:
- Publication type:
- letter
Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease.
- Published in:
- Respirology, 2022, v. 27, n. 10, p. 854, doi. 10.1111/resp.14301
- By:
- Publication type:
- Article
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 9, p. 3881, doi. 10.1007/s12325-022-02229-8
- By:
- Publication type:
- Article
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02455-6
- By:
- Publication type:
- Article
FGF19 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2022, v. 67, n. 2, p. 173, doi. 10.1165/rcmb.2021-0246OC
- By:
- Publication type:
- Article
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
- Published in:
- Respirology, 2022, v. 27, n. 8, p. 635, doi. 10.1111/resp.14267
- By:
- Publication type:
- Article
Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 9, p. 1084, doi. 10.1164/rccm.202106-1485OC
- By:
- Publication type:
- Article
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2022, v. 66, n. 3, p. 260, doi. 10.1165/rcmb.2020-0504OC
- By:
- Publication type:
- Article
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease.
- Published in:
- Annals of the American Thoracic Society, 2022, v. 19, n. 1, p. 20, doi. 10.1513/AnnalsATS.202102-216OC
- By:
- Publication type:
- Article
Treatment Initiation in Patients with Interstitial Lung Disease in Canada.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 17, p. 9316, doi. 10.3390/ijms22179316
- By:
- Publication type:
- Article
Systemic Sclerosis and Associated Interstitial Lung Disease in Ontario, Canada: An Examination of Prevalence and Survival Over 10 Years.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study.
- Published in:
- Respirology, 2021, v. 26, n. 7, p. 683, doi. 10.1111/resp.14066
- By:
- Publication type:
- Article
A Robust Protocol for Decellularized Human Lung Bioink Generation Amenable to 2D and 3D Lung Cell Culture.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1538, doi. 10.3390/cells10061538
- By:
- Publication type:
- Article
Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib.
- Published in:
- Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary Medicine, 2021, p. 1, doi. 10.1177/11795484211006050
- By:
- Publication type:
- Article
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib.
- Published in:
- Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary Medicine, 2021, p. 1, doi. 10.1177/11795484211006050
- By:
- Publication type:
- Article
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Spectral analysis of the diffusion operator with random jumps from the boundary.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58083-7
- By:
- Publication type:
- Article
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE).
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
- Published in:
- European Respiratory Review, 2019, v. 28, n. 153, p. 1, doi. 10.1183/16000617.0029-2019
- By:
- Publication type:
- Article
Molecular breath analysis for IPF: Can we make a few breaths count?
- Published in:
- Respirology, 2019, v. 24, n. 5, p. 404, doi. 10.1111/resp.13503
- By:
- Publication type:
- Article